TSPYL4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.927600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.526400E-01
Normal-vs-Stage2
1.424590E-01
Normal-vs-Stage3
3.323900E-02
Normal-vs-Stage4
6.862000E-01
Stage1-vs-Stage2
2.286200E-01
Stage1-vs-Stage3
1.046590E-01
Stage1-vs-Stage4
9.513200E-01
Stage2-vs-Stage3
2.234000E-01
Stage2-vs-Stage4
1.489670E-02
Stage3-vs-Stage4
7.512100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.368800E-01
Normal-vs-AfricanAmerican
2.522400E-01
Normal-vs-Asian
2.162600E-01
Caucasian-vs-AfricanAmerican
3.811400E-01
Caucasian-vs-Asian
1.855640E-01
AfricanAmerican-vs-Asian
7.556200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.688600E-01
Normal-vs-Female
7.313800E-01
Male-vs-Female
8.775600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.578400E-01
Normal-vs-Age(41-60Yrs)
8.161400E-01
Normal-vs-Age(61-80Yrs)
6.820200E-01
Normal-vs-Age(81-100Yrs)
2.400200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.964800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.061400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.445600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.189200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.316900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.044300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.344100E-02
Normal-vs-Daily Drinker
1.913420E-01
Normal-vs-Weekly Drinker
2.923000E-01
Normal-vs-Occasional Drinker
8.375000E-01
Normal-vs-Social Drinker
9.598000E-01
Non Drinker-vs-Daily Drinker
9.614800E-01
Non Drinker-vs-Weekly Drinker
4.378200E-01
Non Drinker-vs-Occasional Drinker
1.622980E-01
Non Drinker-vs-Social Drinker
9.403700E-02
Daily Drinker-vs-Weekly Drinker
5.124600E-01
Daily Drinker-vs-Occasional Drinker
1.634970E-01
Daily Drinker-vs-Social Drinker
7.592000E-02
Weekly Drinker-vs-Occasional Drinker
2.480200E-01
Weekly Drinker-vs-Social Drinker
2.484400E-01
Occasional Drinker-vs-Social Drinker
6.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.883000E-01
Normal-vs-Grade 2
1.149220E-01
Normal-vs-Grade 3
1.000610E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.776500E-02
Grade 1-vs-Grade 3
8.640300E-02
Grade 1-vs-Grade 4
3.883000E-01
Grade 2-vs-Grade 3
8.751200E-01
Grade 2-vs-Grade 4
1.149220E-01
Grade 3-vs-Grade 4
1.000610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.374600E-01
Normal-vs-NonDiabetic
7.512400E-01
Diabetic-vs-NonDiabetic
3.066200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.079800E-02
Normal-vs-NoPancreatitis
7.343000E-01
Pancreatitis-vs-NoPancreatitis
8.797500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.594600E-01
Normal-vs-N1
1.757210E-01
N0-vs-N1
6.184000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.027600E-02
Normal-vs-TP53-NonMutant
9.060200E-01
TP53-Mutant-vs-TP53-NonMutant
2.857300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
